Sponsor:
National Institute on Drug Abuse (NIDA)
Code:
NCT05143424
Conditions
Opioid Use Disorder
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Interventions
Morphine Sulfate
Brief summary:
Conditions
Opioid Use Disorder
Study ID
NCT05143424
Start date
Nov 4, 2021
Status verified date
Mar, 2024
Completion date
Dec 1, 2024
Anticipated
Primary completion date
Sep 1, 2023
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Diagnostic
Arms
active comparator: CBD (350 mg)
active comparator: CBD (700 mg)
Interventions
Morphine Sulfate
Primary outcome measure
Central contacts
Locations
AltaSciences
Recruiting
Overland Park, Kansas, United States, 66212
Contacts
Principal Investigator:
Debra Kelsh, MD
Sponsor
National Institute on Drug Abuse (NIDA)
Last update posted
Mar 27, 2024
Last verified
Mar, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-22. This information was provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA) on 2024-03-27. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.